Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence Free Survival × Panitumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 100 Colonic Neoplasms 28 Neoplasm Metastasis 26 Rectal Neoplasms 25 Neoplasms 21 Carcinoma, Non-Small-Cell Lung 13 Esophageal Neoplasms 10 Pancreatic Neoplasms 9 Head and Neck Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Lung Neoplasms 7 Colorectal Cancer Metastatic 6 Cholangiocarcinoma 6 Carcinoma, Squamous Cell 6 Breast Neoplasms 6 Carcinoma 5 Recurrence 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Triple Negative Breast Neoplasms 3 Gastrointestinal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Kidney Neoplasms 2 Inflammatory Breast Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2 Advanced Solid Tumors 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06314997 2024-03-18

Liquid-DRER2

Matteo's Friends

Phase 2 Recruiting

Recurrence Free Survival

Data powered by HemOnc (CC BY 4.0) Colophon ⚡